{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:50:43Z","timestamp":1788562243144,"version":"build-2803163510"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ejcts\/ezy020","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T07:11:27Z","timestamp":1515568287000},"page":"700-707","source":"Crossref","is-referenced-by-count":19,"title":["Hypertrophic obstructive cardiomyopathy: what, when, why, for whom?"],"prefix":"10.1093","volume":"53","author":[{"given":"Carlos A","family":"Mestres","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Herzzentrum University Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"},{"name":"Department of Cardiothoracic and Vascular Surgery, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bartel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Sorgente","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cardiology, Tirol Kliniken, University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Gruner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Herzzentrum University Hospital Z\u00fcrich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Dearani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Quintana","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Hospital Clinic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"key\n\t\t\t\t20180312035253_ezy020-B1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B3","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2011.10.020","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives","volume":"60","author":"Maron","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000658-196108000-00003","article-title":"Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy","volume":"154","author":"Morrow","year":"1961","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.athoracsur.2013.04.073","article-title":"Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy","volume":"96","author":"Kunkala","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ncpcardio0965","article-title":"Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy\u2014the Mayo clinic experience","volume":"4","author":"Dearani","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jacc.2015.06.1333","article-title":"Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction","volume":"66","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/eurheartj\/ehr013","article-title":"Controversies in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: alcohol septal ablation","volume":"32","author":"Fifer","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/eurheartj\/ehr006","article-title":". Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back to European patients","volume":"32","author":"Maron","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/eurheartj\/ehw038","article-title":"Discount treatment for HOCM: as good as surgery?","volume":"37","author":"Sigwart","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B13","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a Multicenter North American registry","volume":"58","author":"Nagueh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00392-004-1028-6","article-title":"Catheterbased therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry","volume":"93","author":"Kuhn","year":"2004","journal-title":"Z Kardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B16","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/eht495","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population","volume":"35","author":"Veselka","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCINTERVENTIONS.110.959718","article-title":"Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy","volume":"4","author":"Jensen","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00392-007-0579-8","article-title":"Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy","volume":"96","author":"Seggewiss","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcin.2008.05.009","article-title":"Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation","volume":"1","author":"Kwon","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcin.2008.07.005","article-title":"Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy. The Baylor and Medical University of South Carolina experience 1996 to 2007","volume":"1","author":"Fernandes","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.euje.2004.01.001","article-title":"Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience","volume":"5","author":"Faber","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcin.2014.05.023","article-title":"Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience","volume":"7","author":"Steggerda","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B23","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e2bd","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B24","doi-asserted-by":"crossref","first-page":"1624.","DOI":"10.1016\/S0140-6736(95)91954-6","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Goodwin","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijcard.2016.02.077","article-title":"Low procedure-related mortality achieved with alcohol septal ablation in European patients","volume":"209","author":"Veselka","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B27","doi-asserted-by":"crossref","first-page":"e005735","DOI":"10.1161\/JAHA.117.005735","article-title":"Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: a long-term follow-up study based on the Euro-Alcohol Septal Ablation Registry","volume":"6","author":"Veselka","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","article-title":"One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response","volume":"96","author":"Faber","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-007-0616-7","article-title":"Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience","volume":"97","author":"Kuhn","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ccd.26293","article-title":"A meta-analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy","volume":"88","author":"Singh","year":"2016","journal-title":"Cathet Cardiovasc Intervent"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","article-title":"Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances","volume":"119","author":"Faber","year":"2007","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B34","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1136\/heartjnl-2014-305593","article-title":"Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy","volume":"100","author":"Balt","year":"2014","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B35","first-page":"CD008523","article-title":"Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy","volume":"5","author":"Qintar","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B36","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00392-010-0116-z","article-title":"The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy","volume":"99","author":"Klopotowski","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B38","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jtcvs.2015.07.063","article-title":"Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: relationship to outcomes","volume":"150","author":"Desai","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.athoracsur.2014.11.020","article-title":"Short and medium term outcomes of surgery for patients with hypertrophic obstructive cardiomyopathy","volume":"99","author":"Parry","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.athoracsur.2007.07.063","article-title":"Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"85","author":"Smedira","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0003-4975(98)00187-8","article-title":"Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy","volume":"65","author":"Schonbeck","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCULATIONAHA.113.003953","article-title":"Surgical myectomy for hypertrophic obstructive cardiomyopathy: the cut that heals","volume":"128","author":"Williams","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"ten Cate","year":"2010","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjcard.2009.02.056","article-title":"Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"104","author":"Noseworthy","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B46","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B48","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2016-309699","article-title":"Obstruction after alcohol septal ablation is associated with cardiovascular mortality events","author":"Veselka","year":"2016","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jtcvs.2015.03.044","article-title":"Septal myectomy after failed alcohol ablation: does previous percutaneous intervention compromise outcomes of myectomy?","volume":"150","author":"Quintana","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.athoracsur.2017.01.083","article-title":"Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement","volume":"104","author":"Greason","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B51","doi-asserted-by":"crossref","first-page":"121.","DOI":"10.1186\/s12872-017-0553-y","article-title":"Living with hypertrophic cardiomyopathy and an implantable defibrillator","volume":"17","author":"Magnusson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B53","doi-asserted-by":"crossref","first-page":"e000198.","DOI":"10.1136\/openhrt-2014-000198","article-title":"A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation?","volume":"2","author":"Ezzat","year":"2015","journal-title":"Open Heart"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","article-title":"Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy","volume":"55","author":"Agarwal","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B55","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/euhj.2002.3285","article-title":"Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes","volume":"23","author":"Firoozi","year":"2002","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/icvts\/ivs352","article-title":"Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?","volume":"16","author":"Knyshov","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B57","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jtcvs.2016.12.038","article-title":"Why we need more septal myectomy surgeons: an emerging recognition","volume":"154","author":"Maron","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5603\/CJ.a2016.0089","article-title":"Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single center","volume":"24","author":"Wojtarowicz","year":"2017","journal-title":"Cardiol J"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ccd.26430","article-title":"Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy","volume":"88","author":"Fortunato de Cano","year":"2016","journal-title":"Cathet Cardiovasc Intervent"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jcin.2015.11.036","article-title":"Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly","volume":"9","author":"Liebregts","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B61","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/jce.12750","article-title":"Hypertrophic cardiomyopathy and implantable defibrillators in Sweden: inappropriate shocks and complications requiring surgery","volume":"26","author":"Magnusson","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2014.12.017","article-title":"Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy","volume":"115","author":"Vriesendorp","year":"2015","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B63","doi-asserted-by":"crossref","first-page":"18.","DOI":"10.1186\/s12947-016-0060-9","article-title":"Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients","volume":"14","author":"Yao","year":"2015","journal-title":"Cardiovasc Ultrasound"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B64","doi-asserted-by":"crossref","first-page":"e006292.","DOI":"10.1161\/JAHA.117.006292","article-title":"How symptomatic should a hypertrophic obstructive cardiomyopathy patient be to consider alcohol septal ablation?","volume":"6","author":"Jones","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacc.2017.02.080","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a word of endorsement","volume":"70","author":"Liebregts","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180312035253_ezy020-B66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2017.06.011","article-title":"Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a word of balance","volume":"70","author":"Sorajja","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/53\/4\/700\/24274541\/ezy020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T03:53:10Z","timestamp":1520826790000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/53\/4\/700\/4847813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,9]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezy020","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,9]]}}}